Hospital violence intervention program set to begin helping patients in August
WLWT highlights UC, Cincinnati Children's collaboration
A joint pediatric and adult hospital violence intervention program led by the University of Cincinnati, UC Health and Cincinnati Children's will launch this August, funded by a $600,000 grant from the city of Cincinnati.
“We've done a great job historically at providing medical care for victims of gun violence, but we needed to do more to provide the necessary support for not only the patients but their families,” Amy Makley, MD, associate professor and associate director of the general surgery residency program in UC's College of Medicine and trauma medical director at UC Medical Center, told WLWT.
The program will hire violence prevention professionals to help victims of gun violence and their families. The program will provide them with resources with links to community-based organizations that provide mental health, housing, employment and food insecurity assistance.
“Unfortunately, for a city of our size, we see too high a number of victims of violence,” Makley said. “Between our two institutions, we see about 500 victims a year."
Featured photo at top: Amy Makley speaks at a press conference announcing the program. Photo/UC Health.
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.